Evaluation of MUC4 glycoprotein as a potential target for immunoliposomes in the treatment of pancreatic adenocarcinoma
The purpose of this study is to understand the extent to which MUC4 (mucin) can be used to improve targeted delivery to pancreatic tumors and specifically whether gemcitabine-loaded, anti-MUC4 immunoliposomes offer any significant advantage over the conventional liposome and free drug in pancreatic...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/d10017136 |